AstraZeneca racks up $275 million with vaccine sales

AstraZeneca racks up $275 million with vaccine sales

By Anna Domanska - May 03, 2021

AstraZeneca’s first-quarter earnings doubled, with its Covid-19 vaccine generating $275 million in revenue. The pharma company’s revenue for the quarter rose 15 percent

Read More